1. Australian Institute of Health and Welfare (AIHW). National Drug Strategy Household Survey 2016: Detailed findings. Drug Statistics Series No. 31. 2017; https://www.aihw.gov.au/getmedia/15db8c15-7062-4cde-bfa4-3c2079f30af3/21028.pdf.aspx?inline=true (accessed Nov 2017).
2. Department of Health. Medicinal cannabis products: overview of regulation. Canberra: Therapeutic Goods Administration, 2017; https://www.tga.gov.au/medicinal-cannabis-products-overview-regulation. (accessed Nov 2017).
3. Department of Health. Access to medicinal cannabis products: steps to using access schemes. Canberra: Therapeutic Goods Administration, 2017; https://www.tga.gov.au/access-medicinal-cannabis-products-steps-using-access-schemes. (accessed Dec 2017).
4. Health Canada. Cannabis for Medical Purposes (FY 2017-18) - Licensed Producers: Monthly Data Ontario: Health Canada. Market Data. 2017; https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/licensed-producers/market-data.html (accessed Nov 2017).
5. The Royal Australian College of General Practitioners (RACGP). RACGP Position statement: Medicinal use of cannabis products. Melbourne: RACGP, 2016; https://www.racgp.org.au/support/policies/clinical-and-practice-management/racgp-position-statement-medicinal-use-of-cannabis-products/ (accessed Oct 2017).